Ryan Specialty (NYSE:RYAN) Price Target Lowered to $64.00 at Wells Fargo & Company

Ryan Specialty (NYSE:RYAN) had its target price dropped by investment analysts at Wells Fargo & Company from $68.00 to $64.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective indicates a potential downside of 3.32% from the stock’s current price.

RYAN has been the topic of a number of other reports. The Goldman Sachs Group upped their price target on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 9th. BMO Capital Markets raised Ryan Specialty from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $65.00 to $75.00 in a research note on Tuesday, September 24th. Barclays boosted their price target on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. Morgan Stanley started coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price objective on the stock. Finally, Keefe, Bruyette & Woods decreased their target price on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating for the company in a research report on Friday, January 10th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Ryan Specialty presently has a consensus rating of “Hold” and an average price target of $74.40.

Ryan Specialty Trading Down 0.2 %

Shares of NYSE RYAN opened at $66.20 on Tuesday. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty has a one year low of $42.21 and a one year high of $75.97. The business has a 50-day moving average price of $68.19 and a two-hundred day moving average price of $65.80. The firm has a market capitalization of $17.33 billion, a PE ratio of 85.97, a PEG ratio of 1.52 and a beta of 0.72.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting the consensus estimate of $0.41. The business had revenue of $604.69 million during the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The firm’s quarterly revenue was up 20.5% compared to the same quarter last year. During the same period last year, the company posted $0.32 earnings per share. As a group, analysts predict that Ryan Specialty will post 1.82 earnings per share for the current fiscal year.

Insider Buying and Selling at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the company’s stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $65.99, for a total value of $2,309,650.00. Following the completion of the transaction, the director now directly owns 35,609 shares in the company, valued at approximately $2,349,837.91. This represents a 49.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director David P. Bolger sold 7,055 shares of Ryan Specialty stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total transaction of $500,058.40. Following the sale, the director now owns 78,149 shares in the company, valued at $5,539,201.12. This represents a 8.28 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 191,402 shares of company stock valued at $12,762,989 in the last 90 days. 11.10% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Ryan Specialty

A number of institutional investors have recently added to or reduced their stakes in the stock. Hollencrest Capital Management bought a new position in shares of Ryan Specialty during the 3rd quarter worth approximately $25,000. Assetmark Inc. acquired a new position in Ryan Specialty during the third quarter worth $34,000. Quarry LP boosted its stake in shares of Ryan Specialty by 109.3% in the 3rd quarter. Quarry LP now owns 808 shares of the company’s stock valued at $54,000 after purchasing an additional 422 shares in the last quarter. GAMMA Investing LLC grew its holdings in shares of Ryan Specialty by 106.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,249 shares of the company’s stock worth $83,000 after purchasing an additional 644 shares during the last quarter. Finally, Signaturefd LLC increased its position in shares of Ryan Specialty by 12.3% during the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after purchasing an additional 148 shares in the last quarter. 84.82% of the stock is owned by institutional investors and hedge funds.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.